The Future of Agriculture Is Biological
How Greater Sacramento Is Building the Ecosystem to Lead a $35 Billion Revolution
Synthetic fertilizers transformed global agriculture in the early 20th century, catalyzed by the Haber-Bosch process and the expansion of international fertilizer trade. Regions like California’s San Joaquin Valley became agricultural powerhouses. But that chemical revolution carried a steep cost: soil degradation, water contamination, pollinator decline, and growing pest resistance. Now, a new revolution is underway—and the Greater Sacramento region is at its epicenter.
Agricultural biologicals—products derived from living organisms and natural materials—are rapidly replacing synthetic chemicals as the future of crop protection and soil health. And the organizations, entrepreneurs, and investors driving this transformation are building their base right here in Northern California, with AgStart leading the charge to turn scientific breakthroughs into commercial realities.
A Market Poised for Explosive Growth
The numbers tell a compelling story for entrepreneurs and investors alike. The global agricultural biologicals market is valued at approximately $17–18 billion in 2025 and is projected to reach $35–44 billion by 2030–32, growing at a compound annual growth rate (CAGR) of 12–14% (Fortune Business Insights; MarketsandMarkets, 2025). In the United States alone, the agricultural biologicals market is estimated at $3.55 billion in 2025 and is expected to nearly double to $6.48 billion by 2030, reflecting a 12.8% CAGR (Mordor Intelligence, 2025).
The biopesticides segment specifically is projected to grow from $8.94 billion in 2025 to $17.68 billion by 2030 at a 14.6% CAGR (MarketsandMarkets, 2025). For context, the broader crop protection chemicals market grows at roughly 5% annually—meaning biologicals are expanding nearly three times faster than their synthetic counterparts.
What’s driving this surge? A convergence of forces: pests developing resistance to chemical agents, tightening regulations worldwide, consumer demand for residue-free food, and the integration of biologicals into precision agriculture and integrated pest management (IPM) strategies.
Global Momentum: From Brazil to the EU to California
Brazil currently leads the world in biological adoption. According to the Brazilian Agricultural Research Corporation (EMBRAPA), 55% of the country’s cultivated land uses some form of biological input, and adoption has grown at roughly 22% annually in recent years—four times the global average (AgriBrasilis, 2025). More than 60% of Brazilian farmers now use biologicals, and the potential area treated with bio-inputs reached 156 million hectares in the 2024–25 growing season (CropLife Brasil, 2025).
In Europe, the Farm to Fork Strategy—a centerpiece of the European Green Deal—set ambitious targets to reduce overall chemical pesticide use and risk by 50% by 2030 (European Commission, 2020). While the legislative path has encountered political headwinds, the directional signal is clear: the regulatory environment is tilting decisively toward biological alternatives. The European agricultural biologicals market is anticipated to reach approximately $5 billion in 2025 (Fortune Business Insights, 2025).
In the United States, adoption still lags at around 10% of farmers compared to Brazil’s 60%+ (AgFunder News, 2025). That gap represents an enormous opportunity. The EPA has been streamlining biopesticide registration processes, and the U.S. market’s projected near-doubling over five years signals that American agriculture is approaching an inflection point—one that entrepreneurs and investors in the Greater Sacramento region are uniquely positioned to capitalize on.
Greater Sacramento: An Innovation Cluster with Proven Results
The Greater Sacramento region has emerged as one of the nation’s most dynamic innovation clusters for agricultural biologicals, and its success is no accident. It is the product of world-class research institutions, a proven track record of commercial successes, and a deliberate ecosystem-building strategy.
The story begins with AgraQuest, an early pioneer in biopesticides headquartered in the region. AgraQuest’s success—culminating in its acquisition by Bayer CropScience for over $400 million—put Greater Sacramento on the global biologicals map and established Bayer’s global biologicals headquarters in West Sacramento.
What followed was a virtuous cycle of innovation. Alumni of AgraQuest went on to found Marrone Bio Innovations (subsequently acquired by Bioceres), BioConsortia, and Invasive Species Corporation. Additional innovators including Botanical Solution Inc. and Pheronym have further deepened the region’s bench strength. Together, these companies represent a concentration of biological expertise that rivals any cluster in the world.
The region’s advantages extend well beyond any single company. UC Davis—ranked the #1 agricultural sciences university in the United States—is just 15 miles from downtown Sacramento, providing a continuous pipeline of top-tier scientific talent. Major global players including Bayer Crop Science, BASF, Novonesis, and Syngenta all maintain research and development operations in the region. California’s Central Valley, the world’s largest patch of Class 1 soil, provides immediate access to millions of acres of farmland for field trials across diverse crop types.
AgStart: The Engine of Commercialization
At the center of this ecosystem sits AgStart, a regional non-profit incubator that has become a nationally recognized leader in helping biological startups navigate the critical journey from laboratory discovery to commercial product.
Founded in 2012 through a partnership between regional economic development leaders and UC Davis, AgStart has supported hundreds of AgriFood startups through its unique combination of shared infrastructure, expert mentorship, and deep ecosystem connections.
The Lab@AgStart, located in downtown Woodland, California, is the only integrated wet lab and food lab in Northern California. The nearly 13,000-square-foot facility features 52 lab benches, a fully equipped bio-fermentation lab where scientists can rapidly grow specific microbes and produce biological materials for trials, as well as coworking space and a certified commercial food lab. When it opened, the Lab@AgStart doubled the region’s wet lab capacity—and demand immediately outstripped supply, with half the benches reserved before the doors even opened.
For entrepreneurs, AgStart dramatically lowers the barriers to entry. Rather than raising hundreds of thousands of dollars for lab equipment and facility build-out before producing a single sample, startups can access shared, world-class infrastructure from day one. AgStart also offers programs that fund expert guidance at no cost to entrepreneurs, facilitate strategic partnerships, and connect companies into supportive regional and national networks including Agtech Nation and Harvest Agtech, which can enable free or low-cost field trials across different crop types.
AgStart’s partnership with Bayer’s LifeHub California further underscores its standing. Through the Golden Ticket competition, AgStart and Bayer provide startups from around the world with a year of fully-paid lab access, mentorship from Bayer’s global experts, and immersion in the Greater Sacramento innovation ecosystem—an offer that attracts applicants from pre-seed through Series A stages worldwide.
Why This Matters for Entrepreneurs and Investors
The convergence of market demand, regulatory tailwinds, and regional infrastructure creates a rare alignment of opportunity:
For entrepreneurs: The biologicals market is growing at double-digit rates with massive unmet demand. The U.S. is years behind Brazil in adoption, meaning the domestic market runway is long. AgStart provides the lab infrastructure, mentorship, partnerships, and ecosystem connections that can take a promising organism from bench-scale to field trial without requiring the capital expenditure that typically stalls early-stage biological companies. UC Davis’s talent pipeline and the region’s concentration of industry expertise mean you’re building your company in the best possible environment.
For investors: Agricultural biologicals represent a category with strong secular growth fundamentals—regulatory pressure on chemicals is tightening globally, pest resistance is increasing, and consumer preferences are shifting toward sustainability. The Greater Sacramento cluster offers a deal flow of science-backed startups with access to field-trial infrastructure and proximity to one of the world’s most productive agricultural regions. VC investment in agricultural biological startups in Latin America alone grew more than 2,000% between 2020 and 2024 (AgFunder News, 2025), signaling the depth of investor conviction in this space.
Join the Biological Revolution
Agriculture is at the threshold of its next great transformation. The shift from synthetic chemicals to biological solutions is not a question of if, but how fast. The Greater Sacramento region—with its unmatched combination of research talent, commercial track record, agricultural proximity, and innovation infrastructure—is where this future is being built.
AgStart invites startups working in agriculture, food, and biotechnology to connect and explore the programs, facilities, and support services available for their growth and commercialization goals. Whether you’re a scientist with a promising microbe, an entrepreneur ready to scale, or an investor looking for the next breakthrough in sustainable agriculture, Greater Sacramento is where you need to be.
Sources & Market Data
- Fortune Business Insights. “Agricultural Biologicals Market Size, Share, Growth Report [2032].” Global market projected at $17.16B (2025) to $43.58B (2032), 14.24% CAGR.
- MarketsandMarkets. “Agricultural Biologicals Market Size, Share, Growth and Forecast.” Market projected at $18.44B (2025) to $34.99B (2030), 13.7% CAGR.
- MarketsandMarkets. “Rising Demand for Sustainable Crop Protection Driving Biopesticides Market Growth.” Biopesticides market at $8.94B (2025) to $17.68B (2030), 14.6% CAGR.
- Mordor Intelligence. “United States Agricultural Biologicals Market Forecasts to 2030.” U.S. market at $3.55B (2025) to $6.48B (2030), 12.8% CAGR.
- EMBRAPA / AgriBrasilis. 55% of Brazil’s cultivated land uses biological inputs; average adoption growth of 22% annually.
- CropLife Brasil (2025). Potential area treated with bio-inputs reached 156 million hectares in 2024–25 season.
- AgFunder News (2025). U.S. biologicals adoption at ~10% vs. Brazil’s 60%+. VC investment in LatAm biologicals grew 2,000%+ from 2020–2024.
- European Commission. Farm to Fork Strategy (2020): targets 50% reduction in chemical pesticide use/risk by 2030.
- AgStart (agstart.org), Greater Sacramento Economic Council, U.S. Economic Development Administration, Valley Vision.
Enjoyed this article? Discover more cleantech innovation and startup resources on our blog page.
ABOUT THE AUTHOR
